Loxo Oncology, Inc.
Overview
Loxo Oncology, Inc. is a subsidiary of Eli Lilly and Company, specializing in the development of highly selective medicines for patients with genetically defined cancers. The company's mission is to create and deliver breakthrough treatments for cancer patients with significant unmet medical needs.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Loxo Oncology, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Loxo Oncology, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.